CreatorsPublishersAdvertisers
View more in
Cancer

Iberdomide Combination Shows Promise and Tolerability in Multiple Myeloma

onclive.com
 2021-09-09

Cover picture for the articleIberdomide combined with dexamethasone and either daratumumab, bortezomib, or carfilzomib showed efficacy and tolerability in patients with relapsed or refractory multiple myeloma. Iberdomide combined with dexamethasone and either daratumumab (Darzalex), bortezomib (Velcade), or carfilzomib (Kyprolis) showed efficacy and tolerability in patients with relapsed or refractory multiple myeloma, according to...

www.onclive.com

Comments / 0

Comments / 0